Application of the Plan-Do-Check-Act Cycle for Managing Immune-Related Adverse Events. Journal of Analytical Oncology, [S. l.], v. 10, p. 61–68, 2021. DOI: 10.30683/1927-7229.2021.10.06. Disponível em: https://www.neoplasiaresearch.com/index.php/jao/article/view/670. Acesso em: 15 apr. 2026.